“This CDST blocked 11,790 unnecessary duplicate test orders in these 2 years, which resulted in a cost savings of $183,586. There were no untoward effects reported associated with this intervention.” Procop et al (2014).
Prevention of duplicate blood tests resulted in cost savings of $183,586 http://ctt.ec/eOcXs+ @ivteam #ivteam
Procop, G.W., Yerian, L.M., Wyllie, R., Harrison, A.M. and Kottke-Marchant, K. (2014) Duplicate laboratory test reduction using a clinical decision support tool. American Journal of Clinical Pathology. 141(5), p.718-23.
Objectives: Duplicate laboratory tests that are unwarranted increase unnecessary phlebotomy, which contributes to iatrogenic anemia, decreased patient satisfaction, and increased health care costs.
Materials and Methods: We employed a clinical decision support tool (CDST) to block unnecessary duplicate test orders during the computerized physician order entry (CPOE) process. We assessed laboratory cost savings after 2 years and searched for untoward patient events associated with this intervention.
Results: This CDST blocked 11,790 unnecessary duplicate test orders in these 2 years, which resulted in a cost savings of $183,586. There were no untoward effects reported associated with this intervention.
Conclusions: The movement to CPOE affords real-time interaction between the laboratory and the physician through CDSTs that signal duplicate orders. These interactions save health care dollars and should also increase patient satisfaction and well-being.
Other intravenous and vascular access resources that may be of interest (External links – IVTEAM has no responsibility for content).
- Guide for intravenous chemotherapy and associated vascular access devices from Macmillan.
- CancerUK IV chemotherapy information.